Finding a certified Spravato treatment program near Miami — one that accepts insurance — is a realistic goal. Several REMS-certified centers serve the greater Miami and South Florida area, and most major insurance plans now cover Spravato (esketamine) for eligible members. The key is understanding what certification actually means, how insurance approval works, and what separates a thorough treatment experience from a basic one.
This guide walks you through the essentials: what Spravato is, how to confirm a center is properly certified, which insurance plans typically cover treatment, and what to look for in a provider near Miami.
What Is Spravato (Esketamine)?
Spravato is an FDA-approved nasal spray containing esketamine — a molecule closely related to the anesthetic ketamine. The FDA first approved Spravato in March 2019 for adults with treatment-resistant depression (TRD), defined as depression that has not responded adequately to at least two oral antidepressants. In August 2020, approval expanded to include adults with major depressive disorder (MDD) who experience acute suicidal ideation or behavior.
In January 2025, the FDA took another significant step, clearing Spravato as a standalone monotherapy for TRD — meaning it can now be prescribed without requiring a concurrent oral antidepressant. Previously, members had to continue taking an oral antidepressant alongside Spravato even if that medication was no longer helping. This expanded indication removed a meaningful barrier for many people.
Spravato works differently from traditional antidepressants. Rather than targeting serotonin or norepinephrine — which is how most SSRIs and SNRIs operate — esketamine acts on the brain’s glutamate system, specifically the NMDA receptor. This distinct mechanism may explain why it can support people whose depression has not responded to conventional medications.
Why REMS Certification Matters
Spravato is available only through a restricted distribution system called the REMS (Risk Evaluation and Mitigation Strategy) program, mandated by the FDA. This isn’t optional — it’s a legal requirement. REMS exists because esketamine can cause sedation, dissociation (a feeling of being detached from your surroundings), respiratory depression, and has potential for misuse.
Here’s what REMS certification requires of a treatment center:
- Facility certification. The healthcare setting must be enrolled in and certified through the REMS program before it can dispense or administer Spravato.
- Supervised self-administration. You self-administer the nasal spray under the direct observation of a healthcare provider — you cannot take Spravato home.
- Post-dose monitoring. A healthcare provider monitors you for at least two hours after each dose, checking blood pressure, sedation levels, and dissociative effects.
- Certified pharmacy supply chain. The medication is dispensed only through REMS-certified pharmacies directly to certified treatment centers.
When evaluating any Spravato provider near Miami, confirming REMS certification is the first step. A center that is not REMS-certified cannot legally administer Spravato.
How Insurance Coverage Works for Spravato
Because Spravato is FDA-approved, most major insurance plans cover it — a significant advantage over off-label IV ketamine, which is typically an out-of-pocket expense. However, “covered” doesn’t mean automatic. Insurance companies layer their own clinical criteria onto the FDA indication, and understanding this process can save you weeks of frustration.
Prior Authorization
Nearly all insurers require prior authorization (PA) before approving Spravato. This means your prescribing clinician submits documentation to your insurance company demonstrating medical necessity. The PA request typically includes:
- A confirmed diagnosis of TRD or MDD with suicidal ideation
- Documentation of at least two failed antidepressant trials (specific medications, doses, and durations)
- Current psychiatric evaluation and treatment plan
- Verification that treatment will occur at a REMS-certified facility
Step Therapy Requirements
Some insurers enforce step therapy, meaning they require you to try (and document failure of) certain medications in a specific order before approving Spravato. If your treatment history doesn’t match their exact protocol, your prescriber may need to provide clinical justification for bypassing it. This is where working with a center experienced in navigating these requirements becomes valuable.
Reauthorization
Initial authorization periods range from one to three months. After that, your insurer may require reauthorization to confirm you’re responding to treatment and that continued sessions remain medically necessary. Reauthorization periods typically range from three to twelve months, depending on the plan.
Which Insurance Plans Cover Spravato?
Most major commercial and government insurance plans cover Spravato for eligible members. Here’s what to expect from common plan types:
- Commercial insurance (Aetna, Cigna, UnitedHealthcare, Blue Cross Blue Shield, Florida Blue, and others): Generally covers Spravato under medical or pharmacy benefits. Out-of-pocket costs — after meeting your deductible — often range from $10 to $50 per session.
- Medicare Part B: Typically covers 80% of Spravato treatment costs after the annual deductible, since treatment is administered in an outpatient clinical setting. Members with supplemental Medicare coverage may have little to no remaining out-of-pocket cost.
- Medicaid: Coverage varies by state. Florida Medicaid may cover Spravato, though prior authorization and formulary requirements apply. Contact your plan directly or ask your treatment center’s insurance team to verify.
- Tricare: Covers Spravato for eligible beneficiaries, generally following similar prior authorization protocols as commercial plans.
At Nushama’s Aventura location, our care coordination team accepts Aetna, Cigna, Florida Blue, Medicare, and UnitedHealthcare for Spravato treatment. We manage the entire prior authorization and benefits verification process before your first session, so you have a clear picture of your financial responsibility upfront.
The Spravato withMe Savings Program
If you have commercial insurance, the manufacturer-sponsored Spravato withMe Savings Program (formerly the Janssen CarePath Savings Program) may reduce your copay to as little as $10 per treatment session. The program covers up to $7,150 in eligible copay costs per calendar year for commercially insured members.
A few important details:
- The savings program is not available for members with government-funded insurance (Medicare, Medicaid, Tricare, or VA benefits).
- Annual maximums and program limits apply.
- Your treatment center’s intake team can help determine eligibility and enroll you before your first session.
This program can make a meaningful difference, especially during the induction phase when sessions are more frequent — typically twice per week for the first month.
What to Look for in a Spravato Treatment Center Near Miami
REMS certification is the baseline requirement, but not all certified centers offer the same experience. Here are factors worth considering as you evaluate providers in the greater Miami and South Florida area:
Clinical Expertise
Look for a center staffed by board-certified psychiatrists or psychiatric nurse practitioners with specific training in esketamine administration. The clinical team should be experienced in managing the effects of dissociation, monitoring blood pressure changes, and adapting dosing protocols to your individual response.
Insurance Navigation Support
The prior authorization process for Spravato can be complex. A center with a dedicated insurance coordination team — one that handles PA submissions, benefits verification, and appeals on your behalf — removes a significant source of stress. Ask whether the center is in-network with your specific plan and whether they provide a cost estimate before treatment begins.
Environment and Comfort
You’ll spend at least two hours at the center during each session. The treatment environment matters. Some centers offer private treatment rooms, comfortable seating, and a calm atmosphere designed to support the experience. Others feel more like standard medical offices. Given the dissociative nature of esketamine, a thoughtful setting can meaningfully impact how you feel during and after each session.
Preparation and Integration Support
Spravato can bring up strong emotions and unfamiliar sensations, especially during early sessions. Centers that offer preparation and integration support — helping you understand what to expect before treatment and process the experience afterward — tend to produce more durable outcomes. Preparation isn’t about scripting the experience; it’s about reducing uncertainty so you can engage with the process more fully.
Coordination With Your Existing Providers
A quality treatment center communicates with your existing psychiatrist, therapist, or primary care provider. Spravato works best as part of a comprehensive care plan, not in isolation. Ask whether the center provides session notes or treatment summaries to your referring clinician.
What to Expect During a Spravato Session
If you haven’t experienced Spravato before, here’s a general overview of a typical session:
- Arrival and check-in. Your care team reviews how you’ve been feeling since your last session, checks blood pressure, and confirms you haven’t eaten within the recommended timeframe.
- Self-administration. You self-administer the nasal spray under the direct observation of a healthcare provider. Dosing typically involves two or three devices, with a five-minute interval between each.
- Monitoring period. After administration, you rest in a comfortable treatment space while the clinical team monitors you for at least two hours. They check blood pressure and assess sedation and dissociation at regular intervals.
- Post-session guidance. Once the monitoring period ends and your care team confirms you’re stable, you’re cleared to leave. You cannot drive, operate machinery, or engage in hazardous activities for the rest of the day. Plan to have someone drive you home.
During the induction phase, sessions typically occur twice weekly for the first four weeks. After that, treatment transitions to once weekly or every other week for maintenance, depending on your response.
Nushama’s Aventura Location: Certified Spravato Treatment Near Miami
Nushama operates a REMS-certified treatment center in Aventura, just north of Miami. Our Aventura location offers Spravato alongside other ketamine-based treatments, with a care model built around medical oversight, insurance accessibility, and individualized support.
What members experience at our Aventura center:
- In-network insurance acceptance for Aetna, Cigna, Florida Blue, Medicare, and UnitedHealthcare
- Full prior authorization management — our care coordination team handles the paperwork, communicates with your insurer, and provides a transparent cost estimate before your first session
- Board-certified psychiatric oversight for medical intake, dosing decisions, and ongoing monitoring
- A treatment environment designed for comfort and calm, with private spaces and a supportive clinical team
- Preparation and integration support to help you get the most from each session
If you’ve been searching for an insurance-covered Spravato program near Miami, we welcome you to book a consultation to verify your benefits and explore whether Spravato may be appropriate for your situation.
Frequently Asked Questions
Is Spravato the same as ketamine?
Not exactly. Spravato contains esketamine, which is the S-enantiomer (mirror-image molecule) of ketamine. While they share a similar mechanism of action on the glutamate system, esketamine is FDA-approved for depression and administered as a nasal spray, whereas IV ketamine is used off-label and delivered intravenously. The FDA approval is what makes Spravato eligible for insurance coverage.
How do I know if I qualify for Spravato?
Most insurance plans require a diagnosis of treatment-resistant depression (meaning you’ve tried at least two antidepressants without adequate response) or MDD with acute suicidal ideation. A psychiatric evaluation confirms eligibility. Your treatment center’s clinical team and insurance coordinators can help determine whether you meet the criteria for both medical and insurance approval.
Can I take Spravato without another antidepressant?
As of the January 2025 FDA expansion, yes — Spravato can be prescribed as a standalone treatment for TRD. Previously, a concurrent oral antidepressant was required. Your prescribing clinician will determine the most appropriate treatment plan for your situation.
How long does a Spravato session take?
Plan for approximately two and a half to three hours total. The nasal spray administration takes about 15 to 20 minutes, followed by at least two hours of monitored observation. You’ll need someone to drive you home afterward.
Does Nushama accept insurance for Spravato at its Aventura location?
Yes. Nushama’s Aventura location accepts Aetna, Cigna, Florida Blue, Medicare, and UnitedHealthcare for Spravato treatment. Our care team manages the prior authorization process and provides a clear cost estimate before treatment begins. Verify your insurance coverage with our intake team to
